• Je něco špatně v tomto záznamu ?

Optimizing Corneal Transplant Safety: The Impact of Mandatory Prion Protein Testing on Iatrogenic Creutzfeldt-Jakob Disease Prevention in the Czech Republic

M. Netuková, M. Okál, P. Studený, V. Kolín, R. Matěj

. 2024 ; 44 (8) : 1022-1025. [pub] 20240918

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25022670

PURPOSE: The purpose of this study was to assess the effectiveness of legally mandated testing for pathogenic prion proteins in corneal tissue donors in the Czech Republic, considering its impact on safety, financial, and temporal costs. METHODS: Between January 2007 and December 2023, standardized brain regions were collected from all corneal tissue donors in the Czech Republic. Tissue samples were tested for the presence of pathogenic prion proteins by the Czech Reference Laboratory for Human Prion Diseases. The testing used a Western blot analysis, using 2 distinct monoclonal anti-PrP antibodies. RESULTS: A total of 8030 donors were tested. Four tested samples were initially weakly positive. Subsequent testing conclusively determined these samples to be negative. The remaining 8026 tests yielded negative results confirming the safety of donor screening. CONCLUSIONS: We did not observe any cases of proven transmissible spongiform encephalopathies (TSEs). TSE testing has consistently confirmed that no patients with TSE have been selected into the corneal donor pool, solidifying the effectiveness of the active surveillance program and exclusion criteria. We propose that these mechanisms effectively prevent patients with TSEs from being included in the corneal tissue donor pool. However, the substantial financial costs and a 2-day delay in processing pose challenges, contributing to graft nonutilization and potential negative impacts on patients in acute need. Moreover, the unique requirement for pathogenic prion testing in the Czech Republic also makes importing any corneal grafts from other countries impossible, as those tissues do not fulfill Czech legal requirements.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25022670
003      
CZ-PrNML
005      
20251023080521.0
007      
ta
008      
251014s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/ICO.0000000000003692 $2 doi
035    __
$a (PubMed)39297313
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Netuková, Magdaléna $u Department of Ophthalmology, 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic $u Eye and Tissue Bank, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $u 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Optimizing Corneal Transplant Safety: The Impact of Mandatory Prion Protein Testing on Iatrogenic Creutzfeldt-Jakob Disease Prevention in the Czech Republic / $c M. Netuková, M. Okál, P. Studený, V. Kolín, R. Matěj
520    9_
$a PURPOSE: The purpose of this study was to assess the effectiveness of legally mandated testing for pathogenic prion proteins in corneal tissue donors in the Czech Republic, considering its impact on safety, financial, and temporal costs. METHODS: Between January 2007 and December 2023, standardized brain regions were collected from all corneal tissue donors in the Czech Republic. Tissue samples were tested for the presence of pathogenic prion proteins by the Czech Reference Laboratory for Human Prion Diseases. The testing used a Western blot analysis, using 2 distinct monoclonal anti-PrP antibodies. RESULTS: A total of 8030 donors were tested. Four tested samples were initially weakly positive. Subsequent testing conclusively determined these samples to be negative. The remaining 8026 tests yielded negative results confirming the safety of donor screening. CONCLUSIONS: We did not observe any cases of proven transmissible spongiform encephalopathies (TSEs). TSE testing has consistently confirmed that no patients with TSE have been selected into the corneal donor pool, solidifying the effectiveness of the active surveillance program and exclusion criteria. We propose that these mechanisms effectively prevent patients with TSEs from being included in the corneal tissue donor pool. However, the substantial financial costs and a 2-day delay in processing pose challenges, contributing to graft nonutilization and potential negative impacts on patients in acute need. Moreover, the unique requirement for pathogenic prion testing in the Czech Republic also makes importing any corneal grafts from other countries impossible, as those tissues do not fulfill Czech legal requirements.
650    _2
$a lidé $7 D006801
650    12
$a transplantace rohovky $x škodlivé účinky $7 D016039
650    12
$a Creutzfeldtova-Jakobova nemoc $x prevence a kontrola $x diagnóza $7 D007562
650    12
$a dárci tkání $7 D014019
650    12
$a prionová bílkovina $x analýza $7 D000072002
650    12
$a iatrogenní nemoci $x prevence a kontrola $7 D007049
650    _2
$a western blotting $7 D015153
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a oční banky $7 D005125
650    _2
$a výběr dárců $7 D046148
650    _2
$a dospělí $7 D000328
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Okál, Marián $u Department of Ophthalmology, 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic $u Eye and Tissue Bank, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $u 3rd Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0009000935383308
700    1_
$a Studený, Pavel $u Department of Ophthalmology, 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic $u Eye and Tissue Bank, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $u 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kolín, Vojtěch $u Eye and Tissue Bank, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $u 3rd Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Pathology, 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic ; and
700    1_
$a Matěj, Radoslav $u 3rd Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Pathology, 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic ; and $u Department of Pathology and Molecular Medicine, 3rd Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
773    0_
$w MED00006006 $t Cornea $x 1536-4798 $g Roč. 44, č. 8 (2024), s. 1022-1025
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39297313 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251014 $b ABA008
991    __
$a 20251023080527 $b ABA008
999    __
$a ok $b bmc $g 2417438 $s 1260833
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 44 $c 8 $d 1022-1025 $e 20240918 $i 1536-4798 $m Cornea $n Cornea $x MED00006006
LZP    __
$a Pubmed-20251014

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace